Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1986-3-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0305-7372
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12 Suppl A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
67-71
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3910224-Antineoplastic Agents,
pubmed-meshheading:3910224-Carboplatin,
pubmed-meshheading:3910224-Clinical Trials as Topic,
pubmed-meshheading:3910224-Drug Resistance,
pubmed-meshheading:3910224-Female,
pubmed-meshheading:3910224-Humans,
pubmed-meshheading:3910224-Middle Aged,
pubmed-meshheading:3910224-Organoplatinum Compounds,
pubmed-meshheading:3910224-Ovarian Neoplasms
|
pubmed:year |
1985
|
pubmed:articleTitle |
Ovarian trials at the Royal Marsden.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|